Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;124(1):303-306.
doi: 10.1007/s13760-023-02303-0. Epub 2023 Jun 10.

Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis

Hussein Algahtani  1   2 , Bader Shirah  3 , Abdulhadi Alqahtani  4 , Nawal Abdelghaffar  5   6 , Samiah Makki  7
Affiliations

Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis

Hussein Algahtani et al. Acta Neurol Belg. 2024 Feb.
No abstract available

Keywords: Half-dose; Multiple sclerosis; Ocrelizumab; Personalized.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
MRI of the brain showing multiple high signal demyelinating plaques on T2-weighted images in the supra and infratentorial levels. On T1-weighted images, few holes were seen
Fig. 2
Fig. 2
MRI of the spine showing a high signal demyelinating plaque in the spinal cord
See this image and copyright information in PMC

References

    1. Dobson R, Giovannoni G. Multiple sclerosis—a review. Eur J Neurol. 2019;26(1):27–40. doi: 10.1111/ene.13819. - DOI - PubMed
    1. Lamb YN. Ocrelizumab: a review in multiple sclerosis. Drugs. 2022;82(3):323–334. doi: 10.1007/s40265-022-01672-9. - DOI - PMC - PubMed
    1. Tohyama S, Oh J, Timm M, et al. Should trigeminal neuralgia be considered a clinically isolated syndrome? Mult Scler. 2023;2:135245852211498. - PMC - PubMed
    1. Syed YY. Ocrelizumab: a review in multiple sclerosis. CNS Drugs. 2018;32(9):883–890. doi: 10.1007/s40263-018-0568-7. - DOI - PubMed
    1. Sabatino JJ, Zamvil SS, Hauser SL. B-cell therapies in multiple sclerosis. Cold Spring Harb Perspect Med. 2019;9(2):a032037. doi: 10.1101/cshperspect.a032037. - DOI - PMC - PubMed

MeSH terms